- Home
- AZTR vs UPXI Comparison
AZTR vs UPXI Comparison
Compare AZTR & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZTR
- UPXI
- Stock Information
- Founded
- AZTR 2014
- UPXI 2018
- Country
- AZTR United States
- UPXI United States
- Employees
- AZTR N/A
- UPXI N/A
- Industry
- AZTR Biotechnology: Pharmaceutical Preparations
- UPXI Medicinal Chemicals and Botanical Products
- Sector
- AZTR Health Care
- UPXI Health Care
- Exchange
- AZTR Nasdaq
- UPXI Nasdaq
- Market Cap
- AZTR 5.0M
- UPXI 4.6M
- IPO Year
- AZTR 2023
- UPXI 2021
- Fundamental
- Price
- AZTR $0.37
- UPXI $2.92
- Analyst Decision
- AZTR
- UPXI Hold
- Analyst Count
- AZTR 0
- UPXI 1
- Target Price
- AZTR N/A
- UPXI $25.00
- AVG Volume (30 Days)
- AZTR 17.8M
- UPXI 71.1K
- Earning Date
- AZTR 03-14-2025
- UPXI 02-14-2025
- Dividend Yield
- AZTR N/A
- UPXI N/A
- EPS Growth
- AZTR N/A
- UPXI N/A
- EPS
- AZTR N/A
- UPXI N/A
- Revenue
- AZTR $97,500.00
- UPXI $18,625,089.00
- Revenue This Year
- AZTR N/A
- UPXI $299.03
- Revenue Next Year
- AZTR N/A
- UPXI N/A
- P/E Ratio
- AZTR N/A
- UPXI N/A
- Revenue Growth
- AZTR N/A
- UPXI 4.75
- 52 Week Low
- AZTR $0.23
- UPXI $2.17
- 52 Week High
- AZTR $12.00
- UPXI $15.91
- Technical
- Relative Strength Index (RSI)
- AZTR 51.23
- UPXI 34.56
- Support Level
- AZTR $0.35
- UPXI $3.35
- Resistance Level
- AZTR $0.45
- UPXI $4.50
- Average True Range (ATR)
- AZTR 0.08
- UPXI 0.36
- MACD
- AZTR 0.01
- UPXI -0.06
- Stochastic Oscillator
- AZTR 36.26
- UPXI 5.39
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products. It reaches consumers through its direct-to-consumer network, wholesale partnerships, and prominent third-party platforms like Amazon.